Categories | Inventors
Technology Overview
OHSU # 1260-E — Rabbit polyclonal antibody directed against human cytomegalovirus protein UL131
Technology Overview
Rabbit polyclonal antisera against human cytomegalovirus (CMV) protein UL131 has been developed. This antisera is useful for research involving CMV. Please refer to the following publication for more information on this antisera.
Aliquot provided: 0.5mL aliquots are provided. A minimum of three (3) aliquots of any combination of polyclonal antisera classified under OHSU Technology #1260 is required for each license/MTA.
Publication
Ryckman B.J., et al. Characterization of the Human Cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J. Virology (2008) 82(1):60-70. Link
Licensing Opportunity
The polyclonal antisera is available for non-exclusive licensing.
Inventors:
Related Technologies
- OHSU # 1260 — Rabbit polyclonal antibodies directed against HCMV proteins gH, gL, UL128, UL130 and UL131
- OHSU # 1260-A — Rabbit polyclonal antibody directed against human cytomegalovirus protein gH
- OHSU # 1260-B — Rabbit polyclonal antibody directed against human cytomegalovirus protein gL
- OHSU # 1260-C — Rabbit polyclonal antibody directed against human cytomegalovirus protein UL128
- OHSU # 1260-D — Rabbit polyclonal antibody directed against human cytomegalovirus protein UL130
Categories: